Wraith J E
Willink Biochemical Genetics Unit, Royal Manchester Children's Hospital, Manchester, UK.
Semin Neonatol. 2002 Feb;7(1):75-83. doi: 10.1053/siny.2001.0088.
Although most lysosomal storage disorders present in infancy or early childhood with a progressive condition often associated with dysmorphism, considerable genetic heterogeneity exists resulting in a range of illnesses that can include a dramatic neonatal presentation. Whilst some conditions present with a characteristic neonatal phenotype (e.g. Niemann-Pick disease type C), the remainder present in a nonspecific way often with non-immune hydrops fetalis. Diagnosis can be helped by appropriate radiological studies and, in some patients, evidence of the storage phenomena can be seen in peripheral blood smears or bone marrow aspirates. Unfortunately, for the majority of affected patients no effective, curative, treatment is possible. New developments in therapy including enzyme replacement therapy and substrate deprivation may improve prognosis in some disorders. It is important to establish an accurate diagnosis, as prenatal testing can then be offered in future pregnancies.
尽管大多数溶酶体贮积症在婴儿期或幼儿期出现,病情呈进行性发展,常伴有畸形,但存在相当大的基因异质性,导致一系列疾病,其中包括严重的新生儿表现。虽然有些疾病具有典型的新生儿表型(如C型尼曼-匹克病),但其余疾病的表现不具特异性,常伴有非免疫性胎儿水肿。适当的放射学检查有助于诊断,在一些患者中,外周血涂片或骨髓穿刺物中可发现贮积现象的证据。不幸的是,对于大多数受影响的患者来说,没有有效的治愈性治疗方法。包括酶替代疗法和底物剥夺在内的治疗新进展可能会改善某些疾病的预后。准确诊断很重要,因为这样在未来的妊娠中就可以进行产前检测。